Chilton Investment Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
3,302
-429
-11% -$147K 0.03% 160
2026
Q1
$1.31M Buy
3,731
+330
+10% +$118K 0.03% 145
2025
Q4
$1.11M Buy
3,401
+560
+20% +$178K 0.02% 144
2025
Q3
$802K Buy
2,841
+785
+38% +$228K 0.02% 161
2025
Q2
$574K Buy
2,056
+374
+22% +$106K 0.01% 147
2025
Q1
$524K Buy
1,682
+250
+17% +$73.8K 0.01% 145
2024
Q4
$373K Buy
1,432
+125
+10% +$37.1K 0.01% 146
2024
Q3
$421K Hold
1,307
0.01% 147
2024
Q2
$408K Buy
1,307
+50
+4% +$14.7K 0.01% 137
2024
Q1
$357K Sell
1,257
-5,521
-81% -$1.62M 0.01% 153
2023
Q4
$1.95M Buy
6,778
+5,477
+421% +$1.49M 0.06% 83
2023
Q3
$350K Sell
1,301
-20
-2% -$4.99K 0.01% 138
2023
Q2
$293K Buy
+1,321
New +$307K 0.01% 144

Other funds holding AMGN

Chilton Investment Company's AMGN Position: Q2 2026 in Review

Chilton Investment Company reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $147K and leaving 3,302 shares worth $1.2M. The position accounts for 0.03% of the portfolio, ranked #160.

Chilton Investment Company first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.95M in Q4 2023. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Chilton Investment Company held 3,302 shares of Amgen worth $1.2M as of Q2 2026.
  • Chilton Investment Company sold 429 Amgen shares in Q2 2026, an estimated $147K.
  • Amgen made up 0.03% of Chilton Investment Company's portfolio in Q2 2026, its #160 holding.
  • Chilton Investment Company first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • Chilton Investment Company's Amgen position peaked at $1.95M in Q4 2023.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Chilton Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.